Metabolism Review

Pathophysiology

Insulin resistance, mechanistically

Insulin resistance is the central lesion in type 2 diabetes and one of the most confidently misexplained concepts in nutrition.

Updated 3 min read 23 citations Evidence strength 4/5

Blood glucose meter with lancing device and test strips laid out together
Roy Zuo · CC BY-SA 4.0 · Wikimedia Commons

What is actually resistant

Insulin instructs muscle and fat to take up glucose and tells the liver to stop producing it. In insulin resistance those instructions are less effective, so the pancreas compensates by producing more. Blood glucose stays normal for years while insulin climbs — which is why the condition is typically well advanced before a routine glucose test detects it. Type 2 diabetes appears when the compensation fails.

A systematic review of the crucial role and mechanism of insulin resistance in metabolic disease is the best single entry point [4].

Mechanism of insulin resistance

The common story is: carbohydrates raise insulin, chronically high insulin causes resistance, therefore carbohydrates cause insulin resistance. Each step contains something true, and the conclusion does not follow.

  • Populations eating very high-carbohydrate traditional diets have historically had low rates of insulin resistance. The relationship is not a simple dose-response with dietary carbohydrate.
  • Ectopic fat is more predictive than carbohydrate intake. Lipid accumulating inside liver and muscle cells interferes with insulin signalling directly.
  • Energy surplus is the common upstream factor. Overfeeding produces insulin resistance regardless of the macronutrient delivering the surplus.
  • Physical inactivity is independently causal. Muscle that is not being used disposes of glucose poorly, which is why bed rest induces measurable insulin resistance within days.

What reverses it

Interventions by strength of evidence
InterventionEffectEvidence
Weight loss, particularly visceral and liver fatLargeStrong and consistent
Combined aerobic + resistance trainingModerate, partly weight-independentMeta-analysis [2]
Reducing sedentary timeModest but realGood
Sleep sufficiencyModestExperimental sleep restriction induces resistance
Specific supplementsSmall at bestWeak

The meta-analysis of combined aerobic and resistance training on glycaemic control [2] is worth singling out because the effect is partly independent of weight change — exercise improves glucose disposal through mechanisms that do not require you to get smaller.

Insulin resistance sits underneath several conditions that are often discussed separately. Adipose tissue dysfunction in polycystic ovary syndrome has been systematically reviewed [3], as has the role of lifestyle modification in PCOS [6]. Gestational diabetes shares much of the same pathophysiology [1]. And the gut microbiome's role in type 2 diabetes has been reviewed [7], an area with strong associations and weak causal evidence in humans.

Herbal remedies for PCOS have also been reviewed systematically [5] — included here mainly because the review is a useful demonstration of how thin that literature is.

Common questions

Can insulin resistance be reversed?
Substantially, in many people, primarily through weight loss and exercise. Remission of type 2 diabetes has been demonstrated in trials using intensive weight management.
Do I need to avoid carbohydrates?
Not necessarily. Reducing them lowers glucose and can help, but total energy, body composition and activity matter more upstream.
Is fasting insulin worth testing?
It detects the problem earlier than fasting glucose does, since insulin rises long before glucose. It is not routinely offered in most health systems.
Does exercise help without weight loss?
Yes — meta-analysis supports glycaemic improvement from training [2], and part of that effect is independent of weight.
Blood sugar monitor with a test strip inserted into the port
Roy Zuo · CC BY-SA 4.0 · Wikimedia Commons
The evidence behind this page A stacked bar showing the composition of the 23 publications cited on this page by study type. 176meta-analysis (17)review (6)
23 publications, 2006–2026. This is a largely observational base. It can establish that things occur together; it cannot settle which one causes the other. Source: this page’s own citation list, below.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. Investigating the effects of antidepressants on measures of insulin resistance in major depressive disorder: A systematic review Wong S, Le GH, Zheng YJ, et al. · Journal of affective disorders · 2026 · Systematic review DOIPubMed 42323987
  2. Role of Reward Dysregulation in the Association Between Depression and Obesity: A Systematical Review Zhang X, Han L, Xiao Y, et al. · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026 · Systematic review DOIPubMed 41502322
  3. Coptidis Rhizoma for Obesity, Diabetes, and Dyslipidemia: An Integrated Meta-Analysis and In Silico Study Kang CY, Yoo YJ, Kim JH, et al. · International journal of molecular sciences · 2026 · Meta-analysis DOIPubMed 42794540
  4. The effects of intermittent fasting on body composition and cardiometabolic health in adults with prediabetes or type 2 diabetes: A systematic review and meta-analysis Khalafi M, Habibi Maleki A, Symonds ME, et al. · Diabetes, obesity & metabolism · 2024 · Meta-analysis DOIPubMed 38956175
  5. Cellular and Molecular Pathophysiology of Gestational Diabetes Torres-Torres J, Monroy-Muñoz IE, Perez-Duran J, et al. · International journal of molecular sciences · 2024 · Systematic review DOIPubMed 39519193Full text
  6. Effects of combined aerobic and resistance training on glycemic control, blood pressure, inflammation, cardiorespiratory fitness and quality of life in patients with type 2 diabetes and overweight/obesity: a systematic review and meta-analysis Al-Mhanna SB, Batrakoulis A, Wan Ghazali WS, et al. · PeerJ · 2024 · Meta-analysis DOIPubMed 38887616Full text
  7. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome Bril F, Ezeh U, Amiri M, et al. · The Journal of clinical endocrinology and metabolism · 2023 · Systematic review DOIPubMed 37329216Full text
  8. The crucial role and mechanism of insulin resistance in metabolic disease Zhao X, An X, Yang C, et al. · Frontiers in endocrinology · 2023 · Systematic review DOIPubMed 37056675Full text
  9. Polycystic ovaries and herbal remedies: A systematic review Manouchehri A, Abbaszadeh S, Ahmadi M, et al. · JBRA assisted reproduction · 2023 · Systematic review DOIPubMed 35916457Full text
  10. Life Modifications and PCOS: Old Story But New Tales Gu Y, Zhou G, Zhou F, et al. · Frontiers in endocrinology · 2022 · Systematic review DOIPubMed 35498415Full text
  11. Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials Patikorn C, Roubal K, Veettil SK, et al. · JAMA network open · 2021 · Systematic review DOIPubMed 34919135Full text
  12. Role of gut microbiota in type 2 diabetes pathophysiology Gurung M, Li Z, You H, et al. · EBioMedicine · 2020 · Systematic review DOIPubMed 31901868Full text
  13. Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis Sampath Kumar A, Maiya AG, Shastry BA, et al. · Annals of physical and rehabilitation medicine · 2019 · Meta-analysis DOIPubMed 30553010
  14. Influence of the intervention of exercise on obese type II diabetes mellitus: A meta-analysis Zou Z, Cai W, Cai M, et al. · Primary care diabetes · 2016 · Meta-analysis DOIPubMed 26553963
  15. [Which pretherapeutic evaluation of a newly diagnosed patient with obstructive sleep apnea syndrome?] Dauvilliers Y, Arnulf I, d'Ortho MP, et al. · Revue des maladies respiratoires · 2010 · Clinical guideline DOIPubMed 21129621
  16. Low birth weight and catch-up-growth associated with metabolic syndrome: a ten year systematic review Nobili V, Alisi A, Panera N, et al. · Pediatric endocrinology reviews : PER · 2008 · Systematic review PubMed 19202511
  17. Beta blockade in diabetic heart failure Lukas MA · Heart failure clinics · 2006 · Meta-analysis DOIPubMed 17386880
  18. Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms Steinberg GR, Valvano CM, De Nardo W, et al. · Journal of hepatology · 2025 · Review DOIPubMed 40032040
  19. GLP-1-based medications: Mechanisms involved in obesity treatment Salvador J · Medicina clinica · 2025 · Review DOIPubMed 40466247
  20. Associated factors and principal pathophysiological mechanisms of type 2 diabetes mellitus Wang L, Li L, Liu J, et al. · Frontiers in endocrinology · 2025 · Review DOIPubMed 40416523Full text
  21. Pathophysiology of Type 2 Diabetes Mellitus Galicia-Garcia U, Benito-Vicente A, Jebari S, et al. · International journal of molecular sciences · 2020 · Review DOIPubMed 32872570Full text
  22. The Pathophysiology of Gestational Diabetes Mellitus Plows JF, Stanley JL, Baker PN, et al. · International journal of molecular sciences · 2018 · Review DOIPubMed 30373146Full text
  23. A comprehensive definition for metabolic syndrome Huang PL · Disease models & mechanisms · 2009 · Review DOIPubMed 19407331Full text